Adam S. Grossman is the CEO of ADMA Biologics, a position he has held since 2011. With over 20 years of experience in the blood and plasma industry, he has a strong background in launching new products and managing sales...

Adam S. Grossman is the CEO of ADMA Biologics, a position he has held since 2011. With over 20 years of experience in the blood and plasma industry, he has a strong background in launching new products and managing sales teams on national and international scales. Notably, he founded ADMA Biologics and served in key roles since its inception in 2007. His educational background includes a B.S. from Duke University and an M.B.A. from Harvard Business School, giving him a solid foundation in both science and business. Under his leadership, the company has focused on bringing innovative therapies to the market.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

A

Adam S. Grossman

CEO of ADMA Biologics

Field of Expertise

Business & Management

Sector of Economy

Healthcare

CEO of ADMA Biologics for

8 years 10 months (Jun 2016 - Present)

Previous Experience

Unknown

Rivals

Competitors/colleagues of Adam S. Grossman

Holdings

See how much did Adam S. Grossman make over time.

Adam Grossman holds approximately 2.3 million shares of ADMA Biologics, representing about 4.9% of the company. His richest period was reported in 2023, where he had significant stock options and most of his wealth tied in the company, with a...

Adam Grossman holds approximately 2.3 million shares of ADMA Biologics, representing about 4.9% of the company. His richest period was reported in 2023, where he had significant stock options and most of his wealth tied in the company, with a total compensation of around $2.57 million, which includes his salary, bonuses, and stock value. However, this is a significant drop from earlier years where his holdings had fewer restrictions and possibly higher valuations in the stock market. Grossman has actively engaged in buying and retaining shares over the years, indicating strong confidence in ADMA's future.

Loading...

Insider Trading

See recent insider trades of Adam S. Grossman.

No insider trades found for this CEO.

Compensation History

See how much did Adam S. Grossman make over time.

In 2023, Adam Grossman's total compensation was approximately $2.57 million, which included a base salary of $750,000, a performance-based bonus of $793,125, and $573,695 worth of vested stock options. This was a substantial increase from 2022 when his total compensation was about $1.46 million. His pay structure is designed to align closely with company performance, reflecting a strong emphasis on hitting specific financial and operational goals set by the Board. His annual cash bonuses are contingent on meeting these milestones, which ensure he is financially invested in the company’s success.

Year

2023

Total Compensation

$4.16M

Salary

$750.00K

Board Justification

The compensation aligns with company performance, peer benchmarking, and retention strategies, with a focus on attracting and retaining top talent.

Bonus

$793.13K

Board Justification

Annual cash bonuses based on performance milestones and objectives established by the Board, paid in March 2024.

Other

$46.80K

Board Justification

Includes employer contributions to 401(k) plan and medical benefits paid by the Company.

Restricted Stock

$2.57M(573.7K RSU)

Board Justification

RSUs granted on March 6, 2023, vesting quarterly over four years, subject to continued service.

Performance Metrics

Performance metrics include achievement of specific financial and operational goals set by the Board.